Re: 'Is a randomized trial of a short course of aminoglycoside added to β-lactam antibiotics for empirical treatment in critically ill patients with sepsis justified?' Pharmacokinetic/pharmacodynamic considerations

Clin Microbiol Infect. 2018 Jun;24(6):666-667. doi: 10.1016/j.cmi.2017.12.019. Epub 2018 Jan 6.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Aminoglycosides*
  • Anti-Bacterial Agents
  • Critical Illness*
  • Humans
  • Sepsis
  • beta-Lactams

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • beta-Lactams